Clarity Capital Partners LLC Purchases 31,611 Shares of Tempus AI, Inc. $TEM

Clarity Capital Partners LLC raised its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 65.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,147 shares of the company’s stock after purchasing an additional 31,611 shares during the quarter. Tempus AI comprises 1.8% of Clarity Capital Partners LLC’s holdings, making the stock its 13th biggest position. Clarity Capital Partners LLC’s holdings in Tempus AI were worth $5,093,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of TEM. Vanguard Group Inc. increased its stake in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after purchasing an additional 5,900,668 shares in the last quarter. ARK Investment Management LLC increased its stake in Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after purchasing an additional 1,981,755 shares in the last quarter. Nikko Asset Management Americas Inc. increased its stake in Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after purchasing an additional 1,021,460 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after purchasing an additional 1,016,384 shares in the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new position in Tempus AI during the 1st quarter valued at approximately $34,119,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on TEM shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research note on Saturday, September 27th. HC Wainwright increased their price objective on shares of Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research note on Friday, September 12th. Piper Sandler reiterated a “neutral” rating on shares of Tempus AI in a research note on Friday, August 8th. Bank of America increased their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Finally, Guggenheim increased their price target on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 26th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Tempus AI has an average rating of “Hold” and an average target price of $71.83.

Tempus AI Stock Performance

TEM opened at $91.66 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The company has a market cap of $15.92 billion, a price-to-earnings ratio of -77.03 and a beta of 4.87. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $97.79. The firm’s fifty day simple moving average is $74.98 and its two-hundred day simple moving average is $63.18.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company’s revenue was up 89.5% compared to the same quarter last year. During the same period last year, the firm posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction on Thursday, September 25th. The shares were sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the transaction, the chief executive officer directly owned 9,141,032 shares of the company’s stock, valued at $699,837,409.92. This trade represents a 3.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Theodore Leonsis sold 44,000 shares of the stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $69.90, for a total transaction of $3,075,600.00. Following the completion of the sale, the director owned 86,756 shares of the company’s stock, valued at $6,064,244.40. This trade represents a 33.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 933,662 shares of company stock valued at $67,909,393. Insiders own 26.27% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.